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ABSTRACT

Prior studies have shown that the biological mixture of the two hydrophobic surfactant
proteins, SP-B and SP-C, produces faster adsorption of the surfactant lipids to an
air/water interface, and that they induce 1-palmitoyl-2-oleoyl phosphatidylethanolamine
(POPE) to form inverse bicontinuous cubic phases. SP-B has a much greater effect than
SP-C on adsorption. If the two proteins induce formation of the bicontinuous structures
and faster adsorption by similar mechanisms, then they should also have differential
ability to form the cubic phases. To test this hypothesis, we measured small angle X-ray
scattering on the individual proteins combined with POPE. SP-B replicated the doserelated ability of the combined proteins to induce the cubic phases at temperatures more
than 25°C below the point at which POPE alone forms the curved inverse-hexagonal
phase. With SP-C, diffraction from cubic structures was either absent or present only
with larger amounts of protein at low intensities. The correlation between the structural
effects of inducing curved structures and the functional effects on the rate of adsorption
fits with the model in which SP-B promotes adsorption by facilitating formation of a
negatively curved, rate-limiting intermediate structure.
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INTRODUCTION

The hydrophobic surfactant proteins (SPs), SP-B and SP-C, accelerate the adsorption of
vesicles containing the surfactant lipids to the alveolar air/water interface. With a clean
interface, devoid of a film, the high surface tension can drive adsorption of vesicles
containing only lipids (1). When surface tension subsequently approaches the
equilibrium spreading value, adsorption requires the proteins (1). Any model of how the
proteins achieve this function must explain two observations. First, the proteins promote
adsorption whether restricted to the vesicles or to preexisting films at the interface (2,3).
These results suggest that the proteins affect a rate-limiting structure that is equally
accessible from both locations. Second, a variety of factors affect the kinetics of
adsorption according to how they alter the curvature of phospholipid leaflets. The
phosphatidylethanolamines (PEs) form the inverse hexagonal (HII) phase, in which
cylindrical monolayers have negative net curvature, with a concave hydrophilic surface.
Gramicidin A enhances the negative net curvature of lipids in the HII phase (4). Both PE
and gramicidin A increase rates of adsorption (3,5-7). Lysophosphatidylcholine, which
forms positively curved micelles, instead inhibits adsorption (7). These results
collectively suggest a model of adsorption that is limited by formation of an hour-glass
structure in which the outer leaflet of the vesicles forms two segments that bend back
upon themselves to insert with the correct orientation into the air/water interface (8,9)
(Fig. 1). Both the net (c1+c2) and Gaussian (c1·c2) curvatures of the monolayers in this
kinetic intermediate would be negative. The proteins would accelerate adsorption by
facilitating the formation of these rate-limiting structures.
Until recently, direct evidence that the proteins can affect curvature has been lacking.
The surfactant lipids, with or without the proteins, form lamellar bilayers, which conceal
any tendency of the lipids to curve. A change in the spontaneous curvature of the leaflets
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induced by the proteins would be cancelled by the oppositely oriented, paired leaflet.
Any change in the flexibility that would facilitate curvature in a transient intermediate
during adsorption would remain unexpressed in the stable bilayer. The proposed effects
of the surfactant proteins could be present in lamellar structures, but they would remain
undetectable.
Lipids can form lamellar bilayers despite a tendency of their leaflets to curve because of a
balance of energies. Curvature of a leaflet requires imperfect packing of acyl chains
(10,11), which would be optimized in planar bilayers. If the energy of disrupted packing
dominates the energy of bending away from the spontaneous curvature, then the leaflets
remain lamellar. Introducing a more negative spontaneous curvature may shift the
balance of energies, allowing the lipids to express effects on the tendency to curve that
would otherwise be hidden. 1-palmitoyl-2-oleoyl phosphatidylethanolamine (POPE)
forms the inverse hexagonal (HII) phase above 71°C. At lower temperatures where POPE
by itself exists as lamellar bilayers, the SPs induce formation of inverse bicontinuous
cubic (QII) phases. In these continuously saddle-shaped bilayers, each monolayer has the
negative net and Gaussian curvatures that characterize the hypothetical rate-limiting
intermediate of adsorption (Fig. 1). These results show directly that the SPs can alter the
curvature of lipid structures.
The advantages of substituting POPE for the surfactant lipids are mixed. The
thermodynamically stable structures allow tests for effects on curvature that would be
functionally important but elusive in transient intermediates, and inapparent in lamellar
bilayers. The motivation, however, for forming the curved structures during adsorption
of the surfactant lipids and with a PE would differ. The reduction in interfacial energy
caused by the nascent film would drive formation of the hypothetical, curved, transient
intermediate during adsorption of the surfactant lipids. The PEs instead form curved
structures because of their effective molecular shape (12-14). Without an understanding
5

of how the proteins induce POPE to form the QII phases, the relevance of that structural
effect to the adsorption of the surfactant lipids is uncertain.
The different abilities of the individual surfactant proteins to promote adsorption provide
a simple test of the predicted relationship between structure and function. SP-B and SPC both promote adsorption, but SP-B achieves its effect in much lower amounts (15). If
induction of the QII phases by the combined proteins reflects effects that contribute to the
acceleration of adsorption, then SP-B should promote the QII phases at much lower levels
than SP-C. The studies reported here tested that hypothesis by using small angle X-ray
scattering (SAXS) to determine how the individual proteins purified from calf surfactant
affect the phase behavior of POPE.
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MATERIALS AND METHODS
Materials:
1-palmitoyl-2-oleoyl phosphatidylethanolamine (POPE) and dioleoyl
phosphatidylcholine (DOPC) were purchased from Avanti Polar Lipids (Alabaster, AL)
and used without further characterization or purification. All reagents and solvents were
ACS grade and obtained commercially from the following sources: NaCl, CaCl2,
chloroform and methanol (Mallinckrodt, Hazelwood, MO); UltraPure™ Na2EDTA-2H2O
(Invitrogen, Grand Island, NY); NaN3 (Fluka Biochemika, Buchs, Switzerland); 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Sigma, St. Louis, MO). Water
was processed and photo-oxidized with ultraviolet light using a NANOpure Diamond
TOC-UV water-purification system (Barnstead/Thermolyne, Dubuque, IA). Extracted
calf surfactant (calf lung surfactant extract, CLSE), provided by Dr. Edmund Egan
(ONY, Inc., Amherst, NY), was obtained by lavaging calf lungs, recovering the
surfactant aggregates by centrifugation, and extracting the hydrophobic constituents from
the pelleted material (16).

Methods:
Separation of the surfactant proteins: The combined hydrophobic proteins were obtained
from CLSE by gel permeation chromatography with a matrix of LH-20 (17,18). SP-B
was separated from the combined proteins by licensed use of a patented procedure
(19,20) based on the preferential partitioning of SP-B and SP-C into different phases
formed by chloroform-methanol-water (21). The upper methanol-rich layer contained
pure SP-B, which was dried by rotary evaporation and resuspended in chloroformmethanol (1:1, v:v). The lower chloroform-rich layer contained both proteins, which
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were separated by gel permeation chromatography on a matrix of LH-60 (22,23) to yield
the purified SP-C. Samples were eluted with a mobile phase of chloroform:methanol
(1:1, v:v) driven by gravity and monitored by optical density at 240 and 280 nm (24).
The extent of the different proteins in different fractions was determined by staining of
proteins separated electrophoretically on polyacrylamide gels.
Biochemical characterization: The content of phospholipid was determined by measuring
the amount of phosphate present (25). Total protein was determined with amido black on
material precipitated by trichloroacetic acid (26). The molecular weights of separated
proteins were established by electrophoresis on polyacrylamide gels containing sodium
dodecyl sulphate (NuPAGE®, Invitrogen, Carlsbad, CA). Reduced samples used
dithiothreitol at a final concentration of 50 mM. Proteins suspended in buffered lithium
dodecyl sulfate were incubated at 70 ºC for 15 min, loaded on 4-12% gradient Bis/Tris
gels, and run at a constant voltage of 200 V. The proteins were detected by incubation
overnight with SYPRO® Ruby stain (Invitrogen, Carlsbad, CA).
Preparation of vesicles: The proteins were combined with the lipids in mixtures of
chloroform and methanol, the ratio of which varied with the content of protein. Solvent
was evaporated initially under a stream of nitrogen followed by incubation overnight at 2
mbar. For studies using small-angle x-ray scattering (SAXS), the lipid-protein mixtures
were dispersed in 2 mM EDTA with 0.002% (w:w) NaN3 to a final concentration of
50 mM phospholipid by hydrating overnight at 4 ºC followed by vigorous vortexing and
cyclic freezing and thawing. The samples were transferred to capillaries (1.0 mm
diameter, 0.01 mm wall thickness; "special glass"; Charles Supper, Natick, MA),
centrifuged at 640 x gmax for 10 min, sealed with flame and epoxy, and stored at 4°C until
use.
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For studies of adsorption, vesicles were suspended in HS buffer (10 mM HEPES pH 7.0,
150 mM NaCl) to a final concentration of 16 mM phospholipid by vortexing, cyclic
freeze-thawing, and extrusion 11 times at room temperature through a polycarbonate
filter with pores of 100 nm (Whatman, Maidstone, U.K.). The average hydrodynamic
radius, determined by dynamic light scattering (Protein Solutions Dynapro, Wyatt, Santa
Barbara, CA), was 75 ± 25 nm for the vesicles containing the individual proteins, and 105
± 32 nm with the combined proteins.
Adsorption: Kinetic measurements of adsorption monitored the fall in the surface tension
of a captive bubble at ambient temperatures after injecting the samples containing the
proteins combined with DOPC into a subphase of HSC (10 mM HEPES pH 7.0, 150 mM
NaCl, 1.5 mM CaCl2) to a final concentration of 0.5 mM phospholipid. The apparatus
used to contain the captive bubble has been described previously (27). A computer
analyzed the imaged profile of the bubble in real time to calculate surface tension and
surface area, and used simple feedback to control infusion and withdrawal of buffer from
the subphase by a syringe pump to hold area constant.
Small angle x-ray scattering: Diffraction was measured on beamline 1-4 at the Stanford
Synchrotron Radiation Lightsource (SSRL). Up to 20 capillaries were mounted on an
aluminum block, the temperature of which was controlled with water pumped from a
circulating bath and monitored with an externally applied thermocouple. Blocktemperatures were converted to sample-temperatures according to relationships
established by melting a series of compounds with known melting points. Samples were
equilibrated for at least 10 minutes at each temperature before exposure to radiation with
a wavelength of 1.488 Å for 120 seconds. Angular dependence was calibrated using
standard samples of silver behenate, cholesterol myristate, and lead stearate. The rings
produced by powder diffraction were radially integrated using the program Fit2D (28) to
obtain plots of intensity versus the scattering vector (q). Lamellar, hexagonal, and cubic
9

space groups were assigned according to the best fit of the measured values of q for the
diffraction peaks to Miller indices allowed for the different structures (29,30). The slopes
of the linear relationship between measured q and allowed values of

l2+m2+n2 provided

the lattice-constants (ao) of the unit cells according to (ao = 2π/slope) for the lamellar and
cubic phases, and (ao = 4π / ( 3 ·slope)) for the hexagonal phase.
The results presented here were obtained using a single set of samples. Measurements
with samples containing the same preparation of protein (SP-B; SP-C; or the combined
proteins) were made at the same sequential temperatures. Three distinct sets of samples,
with some measurements on beamline 4-2, produced comparable results, although in one
case, samples with the larger amounts of SP-C did produce minor peaks with QII spacing.
Intensities were well below the levels for samples with the combined proteins and with
SP-B. Resuspension of the lipid-protein mixtures in HSC rather than EDTA produced no
effect on the results.
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RESULTS

Our samples used proteins that were separated from the surfactant lipids by established
methods (17,18,23). The combined proteins provided by this procedure were then
separated from each other using a licensed protocol based on the differential extraction of
the individual proteins (19,20). Electrophoresis on gradient gels showed molecular
weights of roughly 21 and 8 kDa for the unreduced and reduced samples of SP-B,
respectively. These mobilities were consistent with results obtained previously for
purified SP–B (24,31). Samples of SP-C produced a band at approximately 7 kDa that
was unchanged by a reducing agent, consistent with the expected behavior of that
monomeric peptide (32). The gels showed minimal cross-contamination of the purified
samples by the other protein (Fig. 2).
Our studies used different lipids to demonstrate the effects of the proteins on adsorption
and induction of the bicontinuous phases. The proteins induce
phosphatidylethanolamines such as POPE to form QII phases (30). These phospholipids
alone, however, adsorb rapidly without the proteins (3,5,6), presumably because of their
tendency to form negatively curved structures. Therefore measurements of how the
proteins affected adsorption used vesicles of DOPC, which by itself lowers surface
tension slowly and incompletely, failing to reach the equilibrium surface tension of ~24
mN/m (1,3,7). When combined with equal amounts of protein (by weight), vesicles with
SP-B reached equilibrium surface tension more rapidly than with SP-C (Fig. 3). The
individual proteins produced an initial fall in surface tension that depended on
concentration, with SP-C in some circumstances producing a greater effect. The final
accelerated approach to the equilibrium surface tension, however, that is characteristic of
adsorption by unilamellar vesicles of pulmonary surfactant (1) occurred earlier for SP-B.
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These results agreed with the previously published finding (15) that SP-B is more
effective in promoting adsorption than SP-C.
Measurements of SAXS for POPE alone and with the combined proteins produced
expected results. POPE by itself converted from one lamellar spacing to another between
21 and 30°C, and to a hexagonal phase beginning at 70°C (Fig. 4,5). These results were
consistent with the calorimetrically determined transitions from Lβ' to Lα phases at 26°C
(33), and from Lα to HII at 71°C (34). The combined proteins induced diffraction at
intervals expected from cubic space groups (Fig. 4,5). In samples containing 0.01% SP,
_
_
diffraction consistent with Pn3m structures began at 61°C; Im3m spacing emerged at
70°C (Fig. 4,5). Increasing amounts of protein lowered the temperature at which the
cubic phases first appeared, reaching 30°C at 5% SP (Fig. 5). The hexagonal phase,
which coexisted with the QII phases in samples containing small amounts of protein, was
absent at > 0.03% SP (Fig. 5). Results with the combined proteins suggested a dosedependent decrease in the lattice-constant of the QII structures that had not been apparent
from our previous measurements (Fig. 6A,C). In other respects, our findings here
confirmed the results reported previously for the combined proteins with POPE (30).
SP-B alone produced similar effects. Like the combined proteins, SP-B produced no
change in either the transition-temperatures of the lamellar phases or their latticeconstants. Small amounts of SP-B, similar to the levels of the combined proteins that
_
achieved the same effect, induced the QII phases (Fig. 4-6). Diffraction for both Pn3m
_
and Im3m space groups appeared with as little as 0.03% SP-B (Figs. 4-6). Like the
combined proteins, greater amounts of SP-B lowered the temperature at which the QII
_
phases appeared, reaching 43°C for the Im3m space group at 5.0% SP-B. Results with
SP-B also suggested the dose-dependent decrease in the lattice-constant of the QII
structures, particularly at the lower temperatures (Fig. 6). In these several respects, SP-B
replicated the effects of the combined proteins on the phase behavior of POPE.
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In contrast, SP-C produced little change in the behavior of the lipids. The protein in
concentrations from 0.01 - 1.0% had no effect on the transition-temperatures or the
lattice-constant for the lamellar or the HII phases. SP-C either failed to produce any
evidence of the QII phases (Fig. 4,5), or, with other preparations not shown here,
produced only traces of QII diffraction with samples containing the larger amounts of
protein. For a single preparation, the hexagonal lattice-constant at 3% SP-C also
decreased from the value with lower amounts of protein, but for the other samples, the
value remained invariant. Any ability of SP-C to alter the structure of the lipids, if
present, was greatly reduced relative to SP-B.
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DISCUSSION

The studies reported here provide a simple test of a model for how the hydrophobic
surfactant proteins promote adsorption. The model predicts that the proteins facilitate
formation of an hourglass-shaped stalk that connects the adsorbing vesicle to the
air/water interface (Fig. 1). Consistent with the model, low amounts of the combined
proteins induce POPE to form QII phases, in which each leaflet has the negative net and
Gaussian curvatures predicted for the rate-limiting kinetic intermediate. The efficiencies
with which the individual proteins promote adsorption are different. If induction of the
QII phases reflects the same mechanisms that lead to faster adsorption, then the two
proteins should have different abilities to generate the QII structures.
Our results confirm that hypothesis. In the same low amounts as the combined proteins,
SP-B induces formation of the QII phases. SP-C, which has much less effect on
adsorption, either fails at all levels to generate cubic diffraction or induces only low
intensity peaks with higher levels of the protein. Our results indicate that, like
adsorption, the ability of the combined proteins to induce formation of the QII phases
reflects primarily the effects of SP-B. These findings establish the correlation between
the structural and functional effects of the two proteins predicted by the model.
These results fit with the available information on the structure of the two proteins and
with the behavior of other lipid-protein mixtures. The primary structure of SP-C consists
mostly of a hydrophobic sequence that would generate a transmembrane helix (32). The
sequence of SP-B instead suggests a series of amphipathic helices that should insert into
the face of a bilayer (35). Although proposals concerning how the two monomeric
peptides in SP-B fit into the disulfide-linked dimer have been conspicuously absent (36),
vibrational spectroscopy supports the extent of amphipathic helices suggested by the
sequence (37). Although some peptides that induce inverse cubic phases (38) form
14

transmembrane helices, peptides with that activity generally form amphipathic helices
(39-44).
The correlation between the structural and functional effects of the proteins supports the
relevance of the QII phases to adsorption. That relationship still requires a common
mechanism that could explain how SP-B can promote both the QII phases and the
hypothetical curved intermediate. Important aspects of both the lipids and the structures
are different. The magnitude of spontaneous curvature should be much less for the
surfactant lipids, which are dominated by constituents (45) that by themselves form only
lamellar phases, than for POPE, which forms the HII phase above 71 °C (34). The
individual lipid leaflets are unpaired in the hypothetical kinetic intermediate, in contrast
to the bilayers of the QII phase. The motivation for forming the two curved structures
would differ, and only the QII phase would represent an equilibrium configuration. Given
these differences, the mechanism by which SP-B could induce the distinct lipids to form
the two structures requires careful consideration.
SP-B may induce formation of the QII phases by effects that are thermodynamic or
kinetic. For thermodynamic processes, the energy of the curved structure includes
contributions from bending, the packing of acyl chains, and the interaction between
adjacent bilayers (46,47). Two of these are probably unimportant. Prior calculations
suggest that the difference between the energy per unit-area of chain-packing for lamellar
and QII phases should be relatively similar (48-50). This limited difference provides little
basis for SP-B to favor the curved structures by affecting chain-packing. Effects on the
energy of interaction between adjacent bilayers also seem unlikely here. Although our
studies included no attempts to measure that energy directly, the absence of any effect by
SP-B on the spacing of the lamellar phases argues against a change in the interaction
energy. The induction of the QII phases by SP-B should reflect effects on the energy of
bending.
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Expressions for the energy of bending indicate the conditions necessary to form the QII
phases. For limited bending of a thin sheet, the energy per unit-area, g, or energydensity, includes independent terms from simple-splay and saddle-splay curvatures. In
each case, the deviation from the spontaneous configuration determines the contribution,
modified by an elastic modulus (51):
_
1
g = 2 κ(c1 + c2 - co)2 + κc1c2

[1]

_
κ and κ are the moduli of simple-splay and Gaussian curvatures, respectively. co is the
spontaneous curvature of simple-splay curvature adopted in the absence of an applied
force; spontaneous Gaussian curvature is unknown. With symmetric bilayers that contain
identical, oppositely oriented monolayers, cbo = 0. (The superscripts b and m indicate
variables for the bilayer and monolayer, respectively). In the QII phases, the midpoint of
the bilayer falls along a minimal surface, at which cb1 = -cb2, eliminating any contribution
from simple-splay curvature. Because cb1·cb2 < 0, the negative energy that would
_
spontaneously produce the QII phases requires κb > 0 (52-54). If SP-B induces POPE to
_
form QII phases by a thermodynamic effect, then the protein acts by increasing κb to a
positive value.
The changes that induce QII phases in bilayers should extend to the monolayers of the
hypothetical intermediate. For monolayers in which a distance, δ, separates the neutral
plane, at which the energies of stretching and curvature uncouple during bending, from
the midpoint of the bilayer (47,54-56),
_
_
κb = 2(κm - 2κmδcmo )

[2]

Formation of a QII phase therefore requires
_
κm - 2κmδcmo > 0
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[3]

Although we performed no direct measurements of cmo or δ, the invariance of the HIIlattice at different levels of SP-B (Fig. 5) make changes in cmo or δ less likely, and
suggests that SP-B achieves its effect by altering one or both moduli of curvature. The
important point, however, is simply that the changes in bilayers reflect alterations in the
characteristics of their monolayers. Whatever combination of changes in the parameters
of the monolayers induce lamellar bilayers to form QII structures should facilitate bending
of the individual leaflets in the hypothetical intermediate that would determine the rate of
adsorption (Fig. 1).
_
The values of κm, κm, and cmo originate in a common source. The lateral stress-profile of
the monolayer determines each of these parameters (52,53,57-61). Without the proteins,
the stress-profile for POPE and the surfactant lipids should differ. SP-B induces POPE to
form the QII phase by shifting the profile. If SP-B generates analogous shifts in the
profile for the surfactant lipids, the protein would produce comparable changes in the
tendency of those lipids to curve. This common mechanism reasonably explains how SPB could facilitate formation of the distinct curved structures by the different lipids.
In addition to these thermodynamic mechanisms, SP-B could also induce QII phases by
kinetic effects. This possibility is supported by the behavior of pure lipids that form
curved structures. Generally these lipids convert during heating directly from Lα to the
HII phase. During repeated cycling through the Lα-HII transition, however, the QII phases
can emerge below the temperature of the HII phase (62). This observation suggests that
the bicontinuous phases may represent the most stable forms at intermediate
temperatures, above the range of the Lα phase and below HII, but that these structures are
kinetically inaccessible. The ability of SP-B to induce the QII phases and promote faster
adsorption could reflect its ability to provide a lower-energy pathway to the curved
structures rather than an effect on their stability.
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In summary, SP-B, but not SP-C, replicates the ability of the combined proteins to induce
POPE to form QII phases more than 25°C below the Lα-HII transition for the lipid alone.
These results fit with a model that explains the much greater ability of SP-B than SP-C to
promote faster adsorption in terms of effects on a rate-limiting structure in which lipid
leaflets have negative net and Gaussian curvatures.
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FIGURE LEGENDS

1. Hypothetical structure of the kinetic intermediate that limits the rate of adsorption.
The outer leaflet of the vesicle must invert to insert into the air/water interface with the
correct orientation. The two principal curvatures of the intermediate structure would
have opposite signs. In the plane perpendicular to the interface, the curvature of the
leaflet (c1 ≡ 1/R1), with its concave hydrophilic face, would by convention be negative.
In the plane parallel to the interface, the curvature (c2 ≡ 1/R2) of the convex hydrophilic
face would be positive.
2. Electrophoretic separation of the hydrophobic surfactant proteins. Labels indicate
lanes containing the following samples: the combined proteins collected together from
CLSE by gel permeation chromatography on a matrix of LH-20 (SP); SP-B separated
from the SP by licensed use of a patented extraction procedure (SP-B); SP-C purified by
extraction of the combined proteins followed by gel permeation chromatography on LH60 (SP-C); molecular-weight markers (MWM) with the indicated molecular weights
(Mol. Wt.). A. Non-reducing lanes: samples without dithiothreitol. B. Reducing lanes:
samples containing 50 mM dithiothreitol.
3. Adsorption of DOPC combined with the different surfactant proteins. Concentrated
aliquots of protein-DOPC mixtures in HS were injected into a subphase of HSC at
ambient temperatures below a captive bubble. The shape of the bubble provided the
basis for calculating surface tension and surface area. Surface area was held constant
using a computer-controlled syringe pump to infuse and withdraw buffer from the
subphase. The time-axis is split to illustrate the different kinetics for adsorption of
samples with SP-B and SP-C.
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4. Diffraction from POPE with the different surfactant proteins at different temperatures.
Samples, dispersed in 2 mM EDTA, contained POPE with: A. the copurified
hydrophobic proteins; B. SP-B; C. SP-C. Labels in each panel indicate the amount of
protein (%, w:w) per phospholipid. The graph omits data at additional temperatures and
amounts of protein for clarity of presentation.
5. Lattice-constant (ao) of structures with the different space groups at different
temperatures. QIIP and QIID indicate bicontinuous cubic phases corresponding to the
_
_
primitive (space group Im3m) and diamond (Pn3m) infinitely periodic minimal surfaces,
respectively. POPE with: A. the copurified SP-B/C; B. SP-B; C. SP-C.
6. Dose-response of the lattice-constants for the QII phases to variable amounts of the
_
combined proteins and SP-B. Panels indicate the lattice-constant of structures with Pn3m
_
or Im3m space groups for POPE mixed with either the combined proteins or SP-B. The
graphs omit results at 30-43°C because the range of protein concentrations that produced
the QII phases at those temperatures was limited.
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